Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh
- PMID: 24903663
- PMCID: PMC4334795
- DOI: 10.1093/infdis/jiu316
Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh
Abstract
Background: Pneumonia is the leading cause of childhood mortality globally. Respiratory syncytial virus (RSV) is the most important viral cause of pneumonia. Maternal serum antibody protects infants from RSV disease. The objective of our study was to characterize RSV antibody levels in mother-infant pairs.
Methods: Serial serum samples were collected from mother-infant pairs in Bangladesh from the third trimester of pregnancy to 72 weeks postpartum and tested using an RSV antibody microneutralization assay. Serologic infection was defined as a 4-fold increase in antibody titer. Maternal antibody half-life was calculated using infant antibody titers from birth to 20 weeks.
Results: The ratio of infant cord blood to maternal serum RSV antibody titers in 149 mother-infant pairs was 1.01 (95% confidence interval [CI], .99-1.03). Maternal RSV antibody titers in the third trimester and at birth were strongly correlated (R = 0.68). Antibody half-life was 38 days (95% CI, 36-42 days). Higher cord blood RSV antibody titers were associated with a lower risk of serologic infection (P = .01) and maintenance of antibody titer above a potentially protective threshold (P < .001).
Conclusions: Efficient transplacental transfer of RSV-specific antibody from mother to the fetus was documented in mother-infant pairs in Asia. Higher cord blood antibody titers were associated with protection from serologic infection.
Keywords: antibody; maternal vaccine; respiratory syncytial virus.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
Figures
![Figure 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4334795/bin/jiu31601.gif)
![Figure 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4334795/bin/jiu31602.gif)
![Figure 3.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4334795/bin/jiu31603.gif)
Comment in
-
The significance of transplacental antibody against respiratory syncytial virus.J Infect Dis. 2014 Nov 15;210(10):1526-8. doi: 10.1093/infdis/jiu323. Epub 2014 Jun 5. J Infect Dis. 2014. PMID: 24903668 No abstract available.
Similar articles
-
Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal.J Clin Virol. 2017 Oct;95:90-95. doi: 10.1016/j.jcv.2017.08.017. Epub 2017 Sep 2. J Clin Virol. 2017. PMID: 28903080 Free PMC article.
-
Transplacental Respiratory Syncytial Virus and Influenza Virus Antibody Transfer in Alaska Native and Seattle Mother-Infant Pairs.J Pediatric Infect Dis Soc. 2021 Apr 3;10(3):230-236. doi: 10.1093/jpids/piaa040. J Pediatric Infect Dis Soc. 2021. PMID: 32369172 Free PMC article.
-
Placental Transfer of Respiratory Syncytial Virus Antibody Among HIV-Exposed, Uninfected Infants.J Pediatric Infect Dis Soc. 2020 Jul 13;9(3):349-356. doi: 10.1093/jpids/piz056. J Pediatric Infect Dis Soc. 2020. PMID: 31549157 Free PMC article.
-
Passive Immunization Strategies to Prevent Severe Respiratory Syncytial Virus Infection Among Newborns and Young Infants.J Pediatric Infect Dis Soc. 2024 Jul 12;13(Supplement_2):S110-S114. doi: 10.1093/jpids/piae058. J Pediatric Infect Dis Soc. 2024. PMID: 38995085 Review.
-
Passive protection against respiratory syncytial virus disease in infants: the role of maternal antibody.Pediatr Infect Dis J. 1994 May;13(5):449-53. doi: 10.1097/00006454-199405000-00037. Pediatr Infect Dis J. 1994. PMID: 8072835 Review.
Cited by
-
Transfer of Respiratory Syncytial Virus Prefusion F Protein Antibody in Low Birthweight Infants.Open Forum Infect Dis. 2024 Jul 22;11(7):ofae314. doi: 10.1093/ofid/ofae314. eCollection 2024 Jul. Open Forum Infect Dis. 2024. PMID: 39040482 Free PMC article.
-
Modelling respiratory syncytial virus age-specific risk of hospitalisation in term and preterm infants.BMC Infect Dis. 2024 May 21;24(1):510. doi: 10.1186/s12879-024-09400-2. BMC Infect Dis. 2024. PMID: 38773455 Free PMC article.
-
Cost-effectiveness Analysis of Maternal Immunization with RSVpreF Vaccine for the Prevention of Respiratory Syncytial Virus Among Infants in Spain.Infect Dis Ther. 2024 Jun;13(6):1315-1331. doi: 10.1007/s40121-024-00975-6. Epub 2024 May 11. Infect Dis Ther. 2024. PMID: 38733493 Free PMC article.
-
Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes.Cochrane Database Syst Rev. 2024 May 2;5(5):CD015134. doi: 10.1002/14651858.CD015134.pub2. Cochrane Database Syst Rev. 2024. PMID: 38695784 Review.
-
Development and comparison of immunologic assays to detect primary RSV infections in infants.Front Immunol. 2024 Jan 12;14:1332772. doi: 10.3389/fimmu.2023.1332772. eCollection 2023. Front Immunol. 2024. PMID: 38283339 Free PMC article.
References
-
- Nair H, Brooks WA, Katz M, et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet. 2011;378:1917–30. - PubMed
-
- Glezen WP, Paredes A, Allison JE, Taber LH, Frank AL. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr. 1981;98:708–15. - PubMed
-
- Eick A, Karron R, Shaw J, et al. The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease. Pediatr Infect Dis J. 2008;27:207–12. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources